1Pietrzyk M, Hoffmann U, Kramer BK. Chronic allograft nephropathy. N Engl J Med,2004,350(12) :1254 -1256.
2Solez K,Colvin RB, Racusen LC, et al. Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy(CAN'). Am J Transplant, 2007,7 (3) : 518 -526.
3Birnbaum LM, Lipman M, Parakevas S, et al. Management of chronic allograft nephropathy: A systematic review. Clin J Am Soc Nephrol, 2009,4:860 - 865.
4Nankivell B, Borrows RJ, Fung CL, et al. The natural history of chronic allograf. N Engl J Med,2003, 349:2326-2333.
5Rush D, Arlen D, Boucher A, et al. Lack of benefit of early protocol biopsiesin renal transplant patients receiving TAC and MMF: A randomized study. Am J Transplant, 2007,7 : 2538 -2545.
7Tang SC, Chan KW, Tang CS, et al. Conversion of cyclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy. Nephrol Dial Transplant, 2006, 21 : 3243 - 3251.
8Meier M, Nitsehke M, Weidtmann B, et al. Slowing the progression of chronic allograft nephropathy by conversion form cyclosporine to tacrolimus: A randomized controlled triM. Transplantation, 2006,81 : 1035 - 1040.
9Irish W, Sherrill B, Brennan DC, et al. Three-year posttransplant graft survival in renal transplant patients with graft function at 6 months receiving tacrelimus or cyclosporin microemulsion within a triple-drug regimen. Transplantation, 2003, 76:1686 - 1690.
10.levnikar A, Arlen D, Barrett B, et al. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure. Transplantation. 2008,15,86(7 ) :953 -960.
6Chapman JR,O'Connell PJ,Nankivell BJ.Chronic renal allograft dysfunction.J Am Soc Nephrol,2005,16:3015-3026.
7Nankivell BJ,Borrows RJ,Fung CL,et al.The natural history of chronic allograft nephropathy.N Engl J Med,2003,349:2326-2333.
8Gill JS,Tonelli M,Mix CH,et al.The effect of maintenance immunosuppression medication on the change in kidney allograft function.Kidney Int,2004,65:692 -699.
9Behdad AFZALI,Anna LT,David JAG.What we can do about chronic allograft nephropathy:Role of immunosuppressive modulations.Kidney Int,2005,68:2429 -2443.
10Pascual M,Curtis J,Delmonico FL,et al.A prospective,randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation.Transplantation,2003,75:1501-1505.
